Acetyl‐l‐carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.2009.05351.xPMID 20633114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation

  2007cited by this paper
• Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

  2007cited by this paper
• Modulation of cardiovascular responses and neurotransmission during peripheral nociception following nNOS antagonism within the periaqueductal gray.

  2007cited by this paper
• Role of astrocytes in grey matter during stroke: a modelling approach.

  2007cited by this paper
• Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death.

  2006cited by this paper
• Reversed Actrocytic GLT-1 during Ischemia is Crucial to Excitotoxic Death of Neurons, but Contributes to the Survival of Astrocytes themselves

  2006influential reference
• Mechanisms of Ischemic Neuroprotection by Acetyl‐l‐carnitine

  2005cited by this paper
• β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

  2005cited by this paper
• Rodent models of focal stroke: Size, mechanism, and purpose

  2005cited by this paper
• The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.

  2005cited by this paper
• Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs.

  2005cited by this paper
• Estrogen attenuates neuronal excitability in the insular cortex following middle cerebral artery occlusion.

  2004cited by this paper
• Acetyl-L-carnitine induces a sustained potentiation of the afterhyperpolarization.

  2004cited by this paper
• AMPA Receptor–Mediated Neurotoxicity: Role of Ca2+ and Desensitization

  2003cited by this paper
• Disruption of Glial Glutamate Transport by Reactive Oxygen Species Produced in Motor Neurons

  2003cited by this paper
• Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats.

  2002cited by this paper
• Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-β-benzyloxyaspartate: [Brain Res. 868 (2000) 105–112]

  2000cited by this paper
• Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate.

  2000cited by this paper
• Glutamate release in severe brain ischaemia is mainly by reversed uptake

  2000cited by this paper
• Phosphonate quinoxalinedione AMPA antagonists

  2000cited by this paper
• Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation.

  2000cited by this paper
• Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker.

  1999cited by this paper
• Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage.

  1999cited by this paper
• Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine.

  1999cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999influential reference
• Increased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat

  1998cited by this paper
• Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?

  1998cited by this paper
• Neuroprotective effects of acetyl-L-carnitine after stroke in rats.

  1997cited by this paper
• Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

  1996cited by this paper
• Acetylcarnitine modulation of the morphology of rat hippocampal synapses.

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Excitatory amino acid release from astrocytes during energy failure by reversal of sodium‐dependent uptake

  1995cited by this paper
• Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex.

  1995cited by this paper
• Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult.

  1995cited by this paper
• Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

  1995cited by this paper
• Acetyl-l-carnitine attenuates neuronal damage in gerbils with transient forebrain ischeia only when givenBefore the insult

  1995cited by this paper
• [Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome].

  1994cited by this paper
• Delayed therapy of experimental global cerebral ischemia with acetyl-l-carnitine in dogs

  1994cited by this paper
• Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-L-carnitine administration.

  1994cited by this paper
• Neuroprotective activity of acetyl‐L‐carnitine: Studies in vitro

  1994cited by this paper
• Changes in Amino Acid Neurotransmitters and Cerebral Blood Flow in the Ischemic Penumbral Region following Middle Cerebral Artery Occlusion in the Rat: Correlation with Histopathology

  1993cited by this paper
• Inhibition of postcardiac arrest brain protein oxidation by acetyl-L-carnitine.

  1993cited by this paper
• Prevention of Postischemic Canine Neurological Injury Through Potentiation of Brain Energy Metabolism by Acetyl‐L‐Carnitine

  1992cited by this paper
• Astrocyte glutamate uptake during chemical hypoxia in vitro.

  1992cited by this paper
• Differing Neurochemical and Morphological Sequelae of Global Ischemia: Comparison of Single‐ and Multiple‐Insult Paradigms

  1992cited by this paper
• Long‐term acetyl‐L‐carnitine treatment in Alzheimer's disease

  1991cited by this paper
• Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo.

  1991cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA.

  1988cited by this paper
• Nerve growth factor binding in aged rat central nervous system: Effect of acetyl‐l‐carnitine

  1988cited by this paper
• A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.

  1986cited by this paper
• Effects of ischemia-like conditions on cultured neurons: protection by low Na+, low Ca2+ solutions

  1986cited by this paper
• Cellular Origin of Ischemia‐Induced Glutamate Release from Brain Tissue In Vivo and In Vitro

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

  1981cited by this paper

• Effects of L-carnitine on aging-related learning changes and glutamate-mediated molecular mechanisms

  2025cites this paper
• Veterinary medical care in rodent models of stroke: Pitfalls and refinements to balance quality of science and animal welfare.

  2025influential citation
• The Role of the Pyruvate Dehydrogenase Complex in the Development of Ischemic-Reperfusion Syndrome

  2022cites this paper
• Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

  2022cites this paper
• Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)

  2021cites this paper
• Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains

  2020cites this paper
• Interplay between NAD+ and acetyl‑CoA metabolism in ischemia-induced mitochondrial pathophysiology.

  2019cites this paper
• Use of Acetyl-L-Carnitine in Gerontological Practice

  2019cites this paper
• Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review

  2019cites this paper
• Metabolomics and Lipidomics of Ischemic Stroke.

  2018cites this paper
• L-Carnitine and extendin-4 improve outcomes following moderate brain contusion injury

  2018cites this paper
• Interplay between mitochondrial metabolism and oxidative stress in ischemic stroke: An epigenetic connection.

  2017cites this paper
• Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments

  2017cites this paper
• [The use of acetyl-L-carnitine in gerontological practice].

  2017cites this paper
• Pyruvate dehydrogenase complex in cerebral ischemia-reperfusion injury

  2016cites this paper
• Acetyl-l-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats

  2016cites this paper
• System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia

  2015cites this paper
• Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study

  2015cites this paper
• Neuroprotective Effects of Acetyl-L-Carnitine Against Oxygen-Glucose Deprivation-Induced Neural Stem Cell Death

  2015cites this paper
• Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study

  2014cites this paper
• Application of L-carnitine as nutritional supplement in veterinary medicine.

  2014cites this paper
• Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia.

  2014cites this paper
• The Effect of l-Carnitine Supplement and Its Derivatives on Cardiovascular Disease

  2013cites this paper
• Augmentation of Normal and Glutamate-Impaired Neuronal Respiratory Capacity by Exogenous Alternative Biofuels

  2013cites this paper
• Method parameters’ impact on mortality and variability in rat stroke experiments: a meta-analysis

  2013cites this paper
• ATP-ases of synaptic plasma membranes in striatum: enzymatic systems for synapses functionality by in vivo administration of L-acetylcarnitine in relation to Parkinson's Disease.

  2013cites this paper
• Neuroprotective Effects of Pre-Treament with l-Carnitine and Acetyl-l-Carnitine on Ischemic Injury In Vivo and In Vitro

  2012influential citation
• Neuroprotection in Stroke

  2012cites this paper
• Effect of In Vivo l-Acetylcarnitine Administration on ATP-ases Enzyme Systems of Synaptic Plasma Membranes from Rat Cerebral Cortex

  2011cites this paper
• Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat Brain

  2011cites this paper
• Vascular Health and Risk Management Dovepress Critical Update for the Clinical Use of L-carnitine Analogs in Cardiometabolic Disorders

  year unknowncites this paper